ArticleJournal of cancer research and clinical oncology2023

Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomes.

Chang Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.